Pure Global

Diagnostic Evaluation Study of the BactInsight Blood Culture System in West-Africa - Trial NCT05722184

Access comprehensive clinical trial information for NCT05722184 through Pure Global AI's free database. This phase not specified trial is sponsored by Institute of Tropical Medicine, Belgium and is currently Not yet recruiting. The study focuses on Bacterial Infections. Target enrollment is 1347 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT05722184
Not yet recruiting
diagnostic test
Trial Details
ClinicalTrials.gov โ€ข NCT05722184
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Diagnostic Evaluation Study of the BactInsight Blood Culture System in West-Africa

Study Focus

Bacterial Infections

BactInsight blood culture system

Observational

diagnostic test

Sponsor & Location

Institute of Tropical Medicine, Belgium

Timeline & Enrollment

N/A

Jun 01, 2023

Dec 01, 2024

1347 participants

Primary Outcome

Time-to-actionable result

Summary

Diagnosis of bloodstream infections (BSI) is done by sampling blood in blood culture bottles
 that are checked for growth in the microbiology laboratory. In LRS, microbiology laboratories
 are however scarce, and BSI cannot be diagnosed, resulting in overuse of antibiotics which
 fuels AMR. For diagnosis of BSI, so-called manual blood culture (equipment-free) systems are
 used in LRS, with daily visual inspection for growth. Compared to automates, manual systems
 are less sensitive, and growth is slower; in addition, training and experience are needed
 before laboratory staff is competent to detect growth when inspecting the blood culture
 bottles.
 
 A simplified blood culture system could enable expanded use of blood cultures in LRS and
 would thus improve BSI treatment. Ongoing research at the Institute of Tropical Medicine, in
 collaboration with Ghent University has resulted in a novel, simple, cheap, open-access and
 robust blood culture system, the Bactinsight blood culture system. This system consists of
 two modules. Firstly, a portable, battery-operated measurement device (turbidimeter), which
 monitors and detects bacterial growth in blood culture bottles based on the turbidity of the
 culture medium caused by bacterial growth. Secondly, optimized blood culture bottles have
 been developed. A second step in blood cultures is the identification of the causing
 organism. Researchers at LETI (Grenoble, France) have developed a lensfree microscope, which
 simplifies and expedites identification of the causative organisms, improving patient's
 diagnosis and more directed antibiotic treatment. The lensfree microscope is an additional
 module for the Bactinsight blood culture system.
 
 In SIMBLE, the Bactinsight blood culture system will be evaluated against reference systems
 in two phases. During the optimization phase in Belgium, the performance of Bactinsight
 turbidimeter + lensfree microscope will be tested in a reference hospital laboratory. In
 parallel, an in vitro laboratory evaluation of the Bactinsight blood culture system
 (turbidimeter + blood culture bottles + lensfree microscope) will be done using spiked blood
 cultures. In the field-testing phase, the ease-of-use, acceptability, adoptability and
 performance of Bactinsight blood culture system will be evaluated in three hospitals in Benin
 and Burkina Faso. The blood culture bottles used for this study will be manufactured in a
 production facility in Benin, that will be installed at the start of the project.

ICD-10 Classifications

Bacterial infection, unspecified
Bacterial, viral and other infectious agents
Other bacterial intestinal infections
Other bacterial diseases
Other specified bacterial intestinal infections

Data Source

ClinicalTrials.gov

NCT05722184

Non-Device Trial